IPO in HK
Investigation Report on China Phosphocreatine Market, 2010-2019 View full size

Investigation Report on China Phosphocreatine Market, 2010-2019

The global epidemic trend shows that cardiovascular disease has become one of the serious threats to human health whose incidence and death rate has exceeded that of mali…

More details

$ 2,000

Add to cart

English
Chinese
Description

The global epidemic trend shows that cardiovascular disease has become one of the serious threats to human health whose incidence and death rate has exceeded that of malignant tumor and leapt to the first. According to the World Health Organization (WHO), about 17 million people die of cardia-cerebrovascular disease, among which 50% die of acute myocardial infarction and cerebral infarction each year in the world. Phosphocreatine, developed by Alfa Wassermann in 1997, has the largest market share compared with other cardiovascular drugs.
According to CRI’s survey, phosphocreatine develops fast after entering China with annual sales value rising from less than CNY 30 million in 2005 to CNY 1.37 billion in 2014 and CAGR during the period of 2005-2014 reaching up to 53.7%. Phosphocreatine enjoys a vast demand in China. Beijing Lifeshine Pharmaceutical Co., Ltd, Haikou Qili Pharmaceutical Co., Ltd, Hebei Tiancheng Pharmaceutical Co., Ltd, Harbin Bolai Pharmaceutical Co., Ltd and Jilin Yinglian Biopharmaceutical Co., Ltd all occupy certain shares of the market, among which Jilin Yinglian Biopharmaceutical Co., Ltd has the largest market share of over 40% with sales value in 2014 reaching up to CNY 560 million. However, Alfa Wassermann (Italy), the original developer of phosphocreatine, had a market share less than 3% in China in 2014.
As Chinese people’s living standards improve and the population ages, the incidence of cardiovascular will keep increasing and the market size of phosphocreatine in China will keep expanding too.

Readers can get at least the following information through this report:
-market share of manufacturers of phosphocreatine in Chinese market
-price of phosphocreatine in Chinese market
-major manufacturers of phosphocreatine in China
-share of different dosage forms of phosphocreatine in Chinese market
-market outlook of phosphocreatine in China

The author suggests the following groups of people purchase this report:
-manufacturers of drugs for cardiovascular disease
-investors/ research institutions interested in Chinese medicine market
-any interest in Chinese medicine market, please contact CRI for customized survey service
Table of Contents
1 Related Concepts of Phosphocreatine
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Phosphocreatine in China
2.1 Patent and Approval Status of Phosphocreatine in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Phosphocreatine in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Phosphocreatine in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Phosphocreatine in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Phosphocreatine in Chinese Hospitals in 2014
6.1 Beijing Lifeshine Pharmaceutical Co., Ltd
6.2 Hebei Tiancheng Pharmaceutical Co., Ltd
6.3 Haikou Qili Pharmaceutical Co., Ltd
6.4 Harbin Bolai Pharmaceutical Co., Ltd
6.5 Jilin Yinglian Biopharmaceutical Co., Ltd
6.6 Alfa Wassermann (Italy) (Trade Name: Neoton)

7 Major Manufacturers of Phosphocreatine in the Chinese Market, 2010-2014
7.1 Beijing Lifeshine Pharmaceutical Co., Ltd
7.2 Hebei Tiancheng Pharmaceutical Co., Ltd
7.3 Harbin Bolai Pharmaceutical Co., Ltd
7.4 Haikou Qili Pharmaceutical Co., Ltd
7.5 Jilin Yinglian Biopharmaceutical Co., Ltd

8 Market Outlook of Phosphocreatine in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

Table of Selected Charts
Chart Patent Status of Phosphocreatine in China
Chart Approval Information of Phosphocreatine in China
Chart Sales Status of Phosphocreatine in China, 2010-2014
Chart Sales Value of Phosphocreatine in China, 2010-2014
Chart Sales Value of Phosphocreatine in Some Regions in China, 2010-2014
Chart Sales Volume of Phosphocreatine in China, 2010-2014
Chart Sales Volume of Phosphocreatine in Some Regions in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Phosphocreatine for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Phosphocreatine Made by Harbin Bolai in China, 2010-2014
Chart Sales Value and Market Share of Phosphocreatine Made by Hebei Tiancheng in China, 2010-2014
Chart Sales Value and Market Share of Phosphocreatine Made by Alfa Wassermann (Italy) in China, 2010-2014
Chart Sales Value and Market Share of Phosphocreatine Injection in China, 2010-2014
Chart Price of Phosphocreatine Made by Beijing Lifeshine Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Phosphocreatine Made by Hebei Tiancheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Phosphocreatine Made by Hebei Tiancheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Phosphocreatine Made by Harbin Bolai Pharmaceutical Co., Ltd in Some Chinese Cities in 2014 in Some Chinese Cities in 2014
Chart Price of Phosphocreatine Made by Jilin Yinglian Biopharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Phosphocreatine Made by Alfa Wassermann (Italy) in Some Chinese Cities in 2014


  • Charts: 30
  • Pages: 30
  • Published Date: 2015/6/4
  • Geography Coverd: China
  • Publisher: China Research & Intelligence

Contact us

Our support hotline is available 24/7.

Phone:86-21-68521029

Contact our expert support team!